GILEAD SCIENCES, INC. (GILD) › Cash & EquivalentsGILEAD SCIENCES, INC. (GILD) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2006: $816.01M2007: $968.09M2008: $1.46B2009: $1.27B2010: $907.88M2011: $9.88B2012: $1.80B2013: $2.11B2014: $10.03B2015: $12.85B2016: $8.23B2017: $7.59B2018: $17.94B2019: $11.63B2020: $6.00B2021: $5.34B2022: $5.41B$5.41B2006Cash & Equivalents (USD)2022Fiscal YearCash & EquivalentsChange YoY2022$5.41B+1.4%2021$5.34B-11.0%2020$6.00B-48.4%2019$11.63B-35.2%2018$17.94B+136.4%2017$7.59B-7.8%2016$8.23B-36.0%2015$12.85B+28.2%2014$10.03B+374.5%2013$2.11B+17.1%2012$1.80B-81.7%2011$9.88B+988.7%2010$907.88M-28.7%2009$1.27B-12.8%2008$1.46B+50.7%2007$968.09M+18.6%2006$816.01M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share